APO Research

APO RESEARCH · REPORT

Cognitive Assessment and Training Healthcare

Selected research

Market Outlook & Growth Opportunities

Global Cognitive Assessment and Training Healthcare Market Outlook and Growth Opportunities 2026

Market perspective

The global Cognitive Assessment and Training Healthcare market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cognitive Assessment and Training Healthcare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cognitive Assessment and Training Healthcare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cognitive Assessment and Training Healthcare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cognitive Assessment and Training Healthcare market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cognitive Assessment and Training Healthcare market include Cambridge Cognition Ltd., Cogstate Ltd., Bracket, MedAvante Inc., Quest Diagnostic, ProPhase, LLC, CogniFit, ERT Clinical and NeuroCog Trials, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cognitive Assessment and Training Healthcare market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cognitive Assessment and Training Healthcare and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cognitive Assessment and Training Healthcare revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cognitive Assessment and Training Healthcare market.

Cognitive Assessment and Training Healthcare Segment by Company

Cambridge Cognition Ltd.

Cogstate Ltd.

Bracket

MedAvante Inc.

Quest Diagnostic

ProPhase, LLC

CogniFit

ERT Clinical

NeuroCog Trials

Brain Resource Company

Cognitive Assessment and Training Healthcare Segment by Type

Pen-and-paper Based Assessment

Hosted Assessment

Biometrics Assessment

Cognitive Assessment and Training Healthcare Segment by Application

Clinical Trials

Screening & Diagnostic

Brain Training

Academic Research

Others

Cognitive Assessment and Training Healthcare Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cognitive Assessment and Training Healthcare status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cognitive Assessment and Training Healthcare key companies, revenue, market share, and recent developments.

3. To split the Cognitive Assessment and Training Healthcare breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cognitive Assessment and Training Healthcare market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cognitive Assessment and Training Healthcare significant trends, drivers, influence factors in global and regions.

6. To analyze Cognitive Assessment and Training Healthcare competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cognitive Assessment and Training Healthcare market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cognitive Assessment and Training Healthcare and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cognitive Assessment and Training Healthcare.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cognitive Assessment and Training Healthcare industry.

Chapter 3: Detailed analysis of Cognitive Assessment and Training Healthcare company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cognitive Assessment and Training Healthcare in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cognitive Assessment and Training Healthcare in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cognitive Assessment and Training Healthcare Industry Trends Table 2. Cognitive Assessment and Training Healthcare Industry Drivers Table 3. Cognitive Assessment and Training Healthcare Industry Opportunities and Challenges Table 4. Cognitive Assessment and Training Healthcare Industry Restraints Table 5. Global Cognitive Assessment and Training Healthcare Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cognitive Assessment and Training Healthcare Revenue Share by Company (2021-2026) Table 7. Global Cognitive Assessment and Training Healthcare Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cognitive Assessment and Training Healthcare Key Company Manufacturing Base & Headquarters Table 9. Global Cognitive Assessment and Training Healthcare Company, Product Type & Application Table 10. Global Cognitive Assessment and Training Healthcare Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cognitive Assessment and Training Healthcare by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Pen-and-paper Based Assessment Table 15. Significant Companies of Hosted Assessment Table 16. Significant Companies of Biometrics Assessment Table 17. Global Cognitive Assessment and Training Healthcare Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Cognitive Assessment and Training Healthcare Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Cognitive Assessment and Training Healthcare Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Cognitive Assessment and Training Healthcare Sales Value Share by Type (2021-2026) Table 21. Global Cognitive Assessment and Training Healthcare Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Clinical Trials Table 23. Significant Companies of Screening & Diagnostic Table 24. Significant Companies of Brain Training Table 25. Significant Companies of Academic Research Table 26. Significant Companies of Others Table 27. Global Cognitive Assessment and Training Healthcare Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Cognitive Assessment and Training Healthcare Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Cognitive Assessment and Training Healthcare Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Cognitive Assessment and Training Healthcare Sales Value Share by Application (2021-2026) Table 31. Global Cognitive Assessment and Training Healthcare Sales Value Share by Application (2027-2032) Table 32. Global Cognitive Assessment and Training Healthcare Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Cognitive Assessment and Training Healthcare Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Cognitive Assessment and Training Healthcare Sales Value Share by Region (2021-2026) Table 35. Global Cognitive Assessment and Training Healthcare Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Cognitive Assessment and Training Healthcare Sales Value Share by Region (2027-2032) Table 37. Global Cognitive Assessment and Training Healthcare Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Cognitive Assessment and Training Healthcare Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Cognitive Assessment and Training Healthcare Sales Value Market Share by Country (2021-2026) Table 40. Global Cognitive Assessment and Training Healthcare Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Cognitive Assessment and Training Healthcare Sales Value Market Share by Country (2027-2032) Table 42. Cambridge Cognition Ltd. Company Information Table 43. Cambridge Cognition Ltd. Business Overview Table 44. Cambridge Cognition Ltd. Cognitive Assessment and Training Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Cambridge Cognition Ltd. Cognitive Assessment and Training Healthcare Product Portfolio Table 46. Cambridge Cognition Ltd. Recent Development Table 47. Cogstate Ltd. Company Information Table 48. Cogstate Ltd. Business Overview Table 49. Cogstate Ltd. Cognitive Assessment and Training Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Cogstate Ltd. Cognitive Assessment and Training Healthcare Product Portfolio Table 51. Cogstate Ltd. Recent Development Table 52. Bracket Company Information Table 53. Bracket Business Overview Table 54. Bracket Cognitive Assessment and Training Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Bracket Cognitive Assessment and Training Healthcare Product Portfolio Table 56. Bracket Recent Development Table 57. MedAvante Inc. Company Information Table 58. MedAvante Inc. Business Overview Table 59. MedAvante Inc. Cognitive Assessment and Training Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. MedAvante Inc. Cognitive Assessment and Training Healthcare Product Portfolio Table 61. MedAvante Inc. Recent Development Table 62. Quest Diagnostic Company Information Table 63. Quest Diagnostic Business Overview Table 64. Quest Diagnostic Cognitive Assessment and Training Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Quest Diagnostic Cognitive Assessment and Training Healthcare Product Portfolio Table 66. Quest Diagnostic Recent Development Table 67. ProPhase, LLC Company Information Table 68. ProPhase, LLC Business Overview Table 69. ProPhase, LLC Cognitive Assessment and Training Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. ProPhase, LLC Cognitive Assessment and Training Healthcare Product Portfolio Table 71. ProPhase, LLC Recent Development Table 72. CogniFit Company Information Table 73. CogniFit Business Overview Table 74. CogniFit Cognitive Assessment and Training Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. CogniFit Cognitive Assessment and Training Healthcare Product Portfolio Table 76. CogniFit Recent Development Table 77. ERT Clinical Company Information Table 78. ERT Clinical Business Overview Table 79. ERT Clinical Cognitive Assessment and Training Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. ERT Clinical Cognitive Assessment and Training Healthcare Product Portfolio Table 81. ERT Clinical Recent Development Table 82. NeuroCog Trials Company Information Table 83. NeuroCog Trials Business Overview Table 84. NeuroCog Trials Cognitive Assessment and Training Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. NeuroCog Trials Cognitive Assessment and Training Healthcare Product Portfolio Table 86. NeuroCog Trials Recent Development Table 87. Brain Resource Company Company Information Table 88. Brain Resource Company Business Overview Table 89. Brain Resource Company Cognitive Assessment and Training Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Brain Resource Company Cognitive Assessment and Training Healthcare Product Portfolio Table 91. Brain Resource Company Recent Development Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Cognitive Assessment and Training Healthcare Product Image Figure 2. Global Cognitive Assessment and Training Healthcare Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cognitive Assessment and Training Healthcare Market Size (2021-2032) & (US$ Million) Figure 4. Global Cognitive Assessment and Training Healthcare Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Pen-and-paper Based Assessment Image Figure 8. Hosted Assessment Image Figure 9. Biometrics Assessment Image Figure 10. Global Cognitive Assessment and Training Healthcare Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Cognitive Assessment and Training Healthcare Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Cognitive Assessment and Training Healthcare Sales Value Share by Type (2021-2032) Figure 13. Clinical Trials Image Figure 14. Screening & Diagnostic Image Figure 15. Brain Training Image Figure 16. Academic Research Image Figure 17. Others Image Figure 18. Global Cognitive Assessment and Training Healthcare Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Cognitive Assessment and Training Healthcare Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Cognitive Assessment and Training Healthcare Sales Value Share by Application (2021-2032) Figure 21. Global Cognitive Assessment and Training Healthcare Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Cognitive Assessment and Training Healthcare Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Cognitive Assessment and Training Healthcare Sales Value (2021-2032) & (US$ Million) Figure 24. North America Cognitive Assessment and Training Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Cognitive Assessment and Training Healthcare Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Cognitive Assessment and Training Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Cognitive Assessment and Training Healthcare Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Cognitive Assessment and Training Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Cognitive Assessment and Training Healthcare Sales Value (2021-2032) & (US$ Million) Figure 30. South America Cognitive Assessment and Training Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Cognitive Assessment and Training Healthcare Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Cognitive Assessment and Training Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Pen-and-paper Based Assessment
  • Hosted Assessment
  • Biometrics Assessment
Applications
  • Clinical Trials
  • Screening & Diagnostic
  • Brain Training
  • Academic Research
  • Others
Companies covered
  • Cambridge Cognition Ltd.
  • Cogstate Ltd.
  • Bracket
  • MedAvante Inc.
  • Quest Diagnostic
  • ProPhase, LLC
  • CogniFit
  • ERT Clinical
  • NeuroCog Trials
  • Brain Resource Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cognitive Assessment and Training Healthcare Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cognitive Assessment and Training Healthcare Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cognitive Assessment and Training Healthcare Market Dynamics
  1. 2.1 Cognitive Assessment and Training Healthcare Industry Trends
  2. 2.2 Cognitive Assessment and Training Healthcare Industry Drivers
  3. 2.3 Cognitive Assessment and Training Healthcare Industry Opportunities and Challenges
  4. 2.4 Cognitive Assessment and Training Healthcare Industry Restraints
3 Cognitive Assessment and Training Healthcare Market by Company
  1. 3.1 Global Cognitive Assessment and Training Healthcare Company Revenue Ranking in 2025
  2. 3.2 Global Cognitive Assessment and Training Healthcare Revenue by Company (2021-2026)
  3. 3.3 Global Cognitive Assessment and Training Healthcare Company Ranking (2024-2026)
  4. 3.4 Global Cognitive Assessment and Training Healthcare Company Manufacturing Base and Headquarters
  5. 3.5 Global Cognitive Assessment and Training Healthcare Company Product Type and Application
  6. 3.6 Global Cognitive Assessment and Training Healthcare Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cognitive Assessment and Training Healthcare Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cognitive Assessment and Training Healthcare Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cognitive Assessment and Training Healthcare Market by Type
  1. 4.1 Cognitive Assessment and Training Healthcare Type Introduction
  2. 4.1.1 Pen-and-paper Based Assessment
  3. 4.1.2 Hosted Assessment
  4. 4.1.3 Biometrics Assessment
  5. 4.2 Global Cognitive Assessment and Training Healthcare Sales Value by Type
  6. 4.2.1 Global Cognitive Assessment and Training Healthcare Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Cognitive Assessment and Training Healthcare Sales Value by Type (2021-2032)
  8. 4.2.3 Global Cognitive Assessment and Training Healthcare Sales Value Share by Type (2021-2032)
5 Cognitive Assessment and Training Healthcare Market by Application
  1. 5.1 Cognitive Assessment and Training Healthcare Application Introduction
  2. 5.1.1 Clinical Trials
  3. 5.1.2 Screening & Diagnostic
  4. 5.1.3 Brain Training
  5. 5.1.4 Academic Research
  6. 5.1.5 Others
  7. 5.2 Global Cognitive Assessment and Training Healthcare Sales Value by Application
  8. 5.2.1 Global Cognitive Assessment and Training Healthcare Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Cognitive Assessment and Training Healthcare Sales Value by Application (2021-2032)
  10. 5.2.3 Global Cognitive Assessment and Training Healthcare Sales Value Share by Application (2021-2032)
6 Cognitive Assessment and Training Healthcare Regional Value Analysis
  1. 6.1 Global Cognitive Assessment and Training Healthcare Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cognitive Assessment and Training Healthcare Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cognitive Assessment and Training Healthcare Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cognitive Assessment and Training Healthcare Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cognitive Assessment and Training Healthcare Sales Value (2021-2032)
  7. 6.3.2 North America Cognitive Assessment and Training Healthcare Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cognitive Assessment and Training Healthcare Sales Value (2021-2032)
  10. 6.4.2 Europe Cognitive Assessment and Training Healthcare Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cognitive Assessment and Training Healthcare Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cognitive Assessment and Training Healthcare Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cognitive Assessment and Training Healthcare Sales Value (2021-2032)
  16. 6.6.2 South America Cognitive Assessment and Training Healthcare Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cognitive Assessment and Training Healthcare Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cognitive Assessment and Training Healthcare Sales Value Share by Country, 2025 VS 2032
7 Cognitive Assessment and Training Healthcare Country-level Value Analysis
  1. 7.1 Global Cognitive Assessment and Training Healthcare Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cognitive Assessment and Training Healthcare Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cognitive Assessment and Training Healthcare Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cognitive Assessment and Training Healthcare Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cognitive Assessment and Training Healthcare Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cognitive Assessment and Training Healthcare Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cognitive Assessment and Training Healthcare Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cambridge Cognition Ltd.
  2. 8.1.1 Cambridge Cognition Ltd. Company Information
  3. 8.1.2 Cambridge Cognition Ltd. Business Overview
  4. 8.1.3 Cambridge Cognition Ltd. Cognitive Assessment and Training Healthcare Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Cambridge Cognition Ltd. Cognitive Assessment and Training Healthcare Product Portfolio
  6. 8.1.5 Cambridge Cognition Ltd. Recent Developments
  7. 8.2 Cogstate Ltd.
  8. 8.2.1 Cogstate Ltd. Company Information
  9. 8.2.2 Cogstate Ltd. Business Overview
  10. 8.2.3 Cogstate Ltd. Cognitive Assessment and Training Healthcare Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cogstate Ltd. Cognitive Assessment and Training Healthcare Product Portfolio
  12. 8.2.5 Cogstate Ltd. Recent Developments
  13. 8.3 Bracket
  14. 8.3.1 Bracket Company Information
  15. 8.3.2 Bracket Business Overview
  16. 8.3.3 Bracket Cognitive Assessment and Training Healthcare Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bracket Cognitive Assessment and Training Healthcare Product Portfolio
  18. 8.3.5 Bracket Recent Developments
  19. 8.4 MedAvante Inc.
  20. 8.4.1 MedAvante Inc. Company Information
  21. 8.4.2 MedAvante Inc. Business Overview
  22. 8.4.3 MedAvante Inc. Cognitive Assessment and Training Healthcare Revenue and Gross Margin (2021-2026)
  23. 8.4.4 MedAvante Inc. Cognitive Assessment and Training Healthcare Product Portfolio
  24. 8.4.5 MedAvante Inc. Recent Developments
  25. 8.5 Quest Diagnostic
  26. 8.5.1 Quest Diagnostic Company Information
  27. 8.5.2 Quest Diagnostic Business Overview
  28. 8.5.3 Quest Diagnostic Cognitive Assessment and Training Healthcare Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Quest Diagnostic Cognitive Assessment and Training Healthcare Product Portfolio
  30. 8.5.5 Quest Diagnostic Recent Developments
  31. 8.6 ProPhase, LLC
  32. 8.6.1 ProPhase, LLC Company Information
  33. 8.6.2 ProPhase, LLC Business Overview
  34. 8.6.3 ProPhase, LLC Cognitive Assessment and Training Healthcare Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ProPhase, LLC Cognitive Assessment and Training Healthcare Product Portfolio
  36. 8.6.5 ProPhase, LLC Recent Developments
  37. 8.7 CogniFit
  38. 8.7.1 CogniFit Company Information
  39. 8.7.2 CogniFit Business Overview
  40. 8.7.3 CogniFit Cognitive Assessment and Training Healthcare Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CogniFit Cognitive Assessment and Training Healthcare Product Portfolio
  42. 8.7.5 CogniFit Recent Developments
  43. 8.8 ERT Clinical
  44. 8.8.1 ERT Clinical Company Information
  45. 8.8.2 ERT Clinical Business Overview
  46. 8.8.3 ERT Clinical Cognitive Assessment and Training Healthcare Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ERT Clinical Cognitive Assessment and Training Healthcare Product Portfolio
  48. 8.8.5 ERT Clinical Recent Developments
  49. 8.9 NeuroCog Trials
  50. 8.9.1 NeuroCog Trials Company Information
  51. 8.9.2 NeuroCog Trials Business Overview
  52. 8.9.3 NeuroCog Trials Cognitive Assessment and Training Healthcare Revenue and Gross Margin (2021-2026)
  53. 8.9.4 NeuroCog Trials Cognitive Assessment and Training Healthcare Product Portfolio
  54. 8.9.5 NeuroCog Trials Recent Developments
  55. 8.10 Brain Resource Company
  56. 8.10.1 Brain Resource Company Company Information
  57. 8.10.2 Brain Resource Company Business Overview
  58. 8.10.3 Brain Resource Company Cognitive Assessment and Training Healthcare Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Brain Resource Company Cognitive Assessment and Training Healthcare Product Portfolio
  60. 8.10.5 Brain Resource Company Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research